trending Market Intelligence /marketintelligence/en/news-insights/trending/4iRnPgNP3eCLYL5aJlBX0A2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Celltrion Q2 profit down 2.2% YOY

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Celltrion Q2 profit down 2.2% YOY

Celltrion Inc. posted a 2.2% year-over-year decrease in its second-quarter net profit and said sales dropped 10.8%.

The Incheon, South Korea-based maker of biosimilars said net profit for the quarter ended June 30 totaled 78.29 billion won, down from 80.04 billion won a year earlier.

Sales fell to 234.98 billion won from 263.44 billion won in the year-ago period.

Operating profit for the quarter was 83.36 billion won, a 21.2% drop from 105.76 billion won in 2018.

As of July 31, US$1 was equivalent to 1,182.30 South Korean won.